How does a telehealth brand get back on Meta after an ad account ban?
Why do telehealth and compounding-pharmacy advertisers get flagged?
Meta's automated review assesses ad copy, creative, destinations, and other signals. Prescription-drug offers, restricted substances, claims about treatment outcomes, and copy that implies a viewer has a particular health condition can raise policy issues. Telehealth and compounding-pharmacy campaigns can cross several of these categories in a single patient journey.
A flag is not a diagnosis of the underlying problem. Check the cited policy, whether the advertised product and geography are eligible, and whether the destination matches the authorization held by the business. A clinic license or LegitScript certification is not a substitute for Meta's category-specific requirements.
What happens when the appeal window closes?
The restriction notice and Business Support Home determine which review options remain. When the self-service appeal is unavailable, collect the decision, asset IDs, verification records, and evidence of the changes made. An eligible support route may clarify whether further review is possible; it does not promise another appeal.
Separate recovery of the original account from planning an eligible future operating model. The original account may remain restricted. Do not create replacement identities or move campaigns into another account to bypass that decision.
What does a policy-permitted rebuild involve?
- 01
Resolve eligibility first
Document the restriction and the affected Page, ad account, business portfolio, domain, and user access. Check clinical and pharmacy licensing, LegitScript certification where required, and Meta's category-specific authorization before choosing a new operating structure. A certification does not make every telehealth or compounded product eligible for advertising.
- 02
Prepare the landing pages
Align the advertised service with the destination, clinical intake, and pharmacy fulfillment model. Review provider identity, claims, privacy notices, pricing disclosures, and certification status. Keep PHI inside clinical systems and separate it from marketing analytics, URLs, pixels, and Conversions API events.
- 03
Rebuild assets only where permitted
Use the existing eligible Page and business portfolio where possible. A new Page, or a new business manager where required, is an option only when Meta permits that structure. Preserve accurate business identity and ownership; replacement assets are not a workaround for an active restriction.
- 04
Manage the vetted partner migration
Where permitted, Mxdify manages the migration into a vetted partner ad-account structure: documented ownership, assigned permissions, verified business relationships, and review of the ads and destinations before launch. We assess the partner's access, operating practices, and policy history before any campaign moves. The partner structure does not transfer eligibility or override enforcement.
How can a brand reduce the risk of a second enforcement action?
Review creative and destinations before launch and after material changes. Check treatment claims, personal-attribute language, product eligibility, certification status, and the permissions of people and partners with account access. Keep a record of approvals and changes so a later review has a clear operating history.
Audit the measurement layer separately: PHI stays in clinical systems, not marketing event payloads. Monitor policy notices and pause affected campaigns while investigating new issues. These controls reduce avoidable exposure; they do not eliminate platform enforcement risk.
How does Mxdify support a Meta recovery?
We audit the restriction and the affected Page, ad account, business portfolio, domain, and user access. We review licensing, LegitScript status, and landing-page eligibility against Meta's category requirements, and we prepare the remediation record — the decision, asset IDs, verification records, and evidence of the changes made — that a review or support channel asks for.
Where Meta permits the structure, we manage the migration into a vetted partner ad-account arrangement and the relaunch that follows: documented ownership, assigned permissions, and review of the ads and destinations before anything goes live. We have run this path with telehealth advertisers before. What we bring is an operator's command of the prerequisites and the policy-permitted paths; Meta alone decides whether access is restored.